CN105056144A - Chinese herb composition for treating cervical spondylosis - Google Patents
Chinese herb composition for treating cervical spondylosis Download PDFInfo
- Publication number
- CN105056144A CN105056144A CN201510539678.1A CN201510539678A CN105056144A CN 105056144 A CN105056144 A CN 105056144A CN 201510539678 A CN201510539678 A CN 201510539678A CN 105056144 A CN105056144 A CN 105056144A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- herba
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a Chinese herb composition for treating cervical spondylosis. The Chinese herb composition comprises, by weight, 50-60 parts of deer horn pieces, 55-62 parts of large-leaved gentian, 55-62 parts of notopterygium roots, 55-62 parts of mulberry twigs, 57-65 parts of Chinese angelica, 57-65 parts of red-rooted salvia roots, 57-65 parts of olibanum, 57-65 parts of myrrh, 55-62 parts of radix curcuma, 55-62 parts of ligusticum wallichii, 55-62 parts of rhizoma atractylodis, 55-60 parts of whole scorpion, 55-60 parts of earthworms, 55-60 parts of stiff silkworms, 55-60 parts of parched pangolin scales, 55-60 parts of Chinese polyphaga, 55-63 parts of garden balsam stems, 55-63 parts of rhizoma gastrodiae, 55-63 parts of pseudo-ginseng, 55-63 parts of drachonis sanguis, 55-63 parts of aconite roots, 55-63 parts of kusnezoff monkshood roots, 55-63 parts of processed semen strychni, 78-83 parts of tortoise plastron, 78-83 parts of zaocys dhumnades, 78-83 parts of clematis roots, 78-83 parts of drynaria rhizomes, 118-125 parts of white peony roots, 118-125 parts of kudzu vine roots and 150-200 parts of centipedes. The natural Chinese herb raw materials are adopted, the herb source is wide, the cost is low, preparation is easy, toxic and side effects are small, and the treatment effect is remarkable.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of Chinese medicine composition for the treatment of cervical spondylosis.
Background technology
Cervical spondylosis refers to that the degenerative such as cervical intervertebral disk changes, and causes osteophytosis, ligament calcification, stimulates or the nerve of compressing cervical region, blood vessel, spinal cord and occur that numb, dizzy etc. with cervical pain, shoulder arm is a kind of syndrome of cardinal symptom and sign.
The Therapeutic Method of cervical spondylosis comprises non-operative treatment and operative treatment.Zhao Dinglin etc. think the cervical spondylosis of no matter which kind of type, should leading non-operative treatment, as poor effect or invalid after row operative treatment again, and most Patients with Cervical Spondylopathy obtains gratifying effect by non-operative treatment and need not perform the operation.Operation can remove compressing to a certain extent, but, ischemia remaining for postoperative blood stasis and inflammation etc. may continue to excite nerve, the problem of root is then difficult to solve, moreover the wound brought of performing the operation can destroy the balance of Human Cervical Spine Modeling and postoperatively to infect, the complication such as fixture loosens, bone grafting does not merge, rejection and damage is increased the weight of further.Cervical Spondylopathy Treated with Chinese Medicine method is numerous, there are oral medicinal herb, traction, acupuncture and tuina-massage, small needle knife, the external application of Chinese medicine and iontophoresis, acupuncture point block etc., take Basic Theories of Chinese Medicine as the Chinese medicine decoction instructed, pass through dialectical treatmert, classification therapy by stages, side's medicine is flexible, with strong points, is one of Main Means for the treatment of cervical spondylosis.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of cervical spondylosis.
In order to realize object of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of cervical spondylosis, it comprises the material of following weight portion: Cornu Cervi tablet 50-60 part, Radix Gentianae Macrophyllae 55-62 part, Rhizoma Et Radix Notopterygii 55-62 part, Ramulus Mori 55-62 part, Radix Angelicae Sinensis 57-65 part, Radix Salviae Miltiorrhizae 57-65 part, Olibanum 57-65 part, Myrrha 57-65 part, Rhizoma Curcumae Longae 55-62 part, Rhizoma Chuanxiong 55-62 part, Rhizoma Atractylodis 55-62 part, Scorpio 55-60 part, Pheretima 55-60 part, Bombyx Batryticatus 55-60 part, stir-baked SQUAMA MANITIS 55-60 part, Eupolyphaga Seu Steleophaga 55-60 part, Herba speranskiae tuberculatae 55-63 part, Rhizoma Gastrodiae 55-63 part, Radix Notoginseng 55-63 part, Sanguis Draxonis 55-63 part, Radix Aconiti 55-63 part, Radix Aconiti Kusnezoffii 55-63 part, Semen Strychni (processed) 55-63 part, Carapax et Plastrum Testudinis 78-83 part, Zaocys 78-83 part, Radix Clematidis 78-83 part, Rhizoma Drynariae 78-83 part, Radix Paeoniae Alba 118-125 part, Radix Puerariae 118-125 part and Scolopendra 150-200 part.
Preferably, the Chinese medicine composition for the treatment of cervical spondylosis of the present invention comprises the material of following weight portion: Cornu Cervi tablet 55 parts, Radix Gentianae Macrophyllae 60 parts, Rhizoma Et Radix Notopterygii 60 parts, Ramulus Mori 60 parts, Radix Angelicae Sinensis 60 parts, Radix Salviae Miltiorrhizae 60 parts, Olibanum 60 parts, Myrrha 60 parts, 60 parts, Rhizoma Curcumae Longae, Rhizoma Chuanxiong 60 parts, Rhizoma Atractylodis 60 parts, Scorpio 58 parts, Pheretima 58 parts, Bombyx Batryticatus 58 parts, stir-baked SQUAMA MANITIS 58 parts, Eupolyphaga Seu Steleophaga 58 parts, Herba speranskiae tuberculatae 60 parts, 60 parts, Rhizoma Gastrodiae, Radix Notoginseng 60 parts, Sanguis Draxonis 60 parts, Radix Aconiti 60 parts, Radix Aconiti Kusnezoffii 60 parts, Semen Strychni (processed) 60 parts, Carapax et Plastrum Testudinis 80 parts, Zaocys 80 parts, Radix Clematidis 80 parts, Rhizoma Drynariae 80 parts, the Radix Paeoniae Alba 120 parts, Radix Puerariae 120 parts and Scolopendra 182 parts.
More preferably, the Chinese medicine composition for the treatment of cervical spondylosis of the present invention also comprises the material of following weight portion: Herba Portulacae Grandiflorae 90 parts, Herba Liparidis nervosae 80 parts, Radix et Rhizoma Iridis Sanguineae 70 parts, Radix seu Caulis fici Martinii grass 75 parts, Herba Psiloti Nudi 80 parts, Herba Cissampelotis pareiae 70 parts, Membrana Follicularis ovi 90 parts, bitter white hoof 80 parts, Semen Sterculiae Nobilis 70 parts, 80 parts, calabash rattan, Herba Desmodii Elegantis 60 parts and Herba Potentillae Fragarioidis 60 parts.
Most preferably, described Chinese medicine composition can be tablet, dispersible tablet, capsule, unguentum or decoction.
The present invention also provides the purposes of compositions in the Chinese medicine of preparation treatment cervical spondylosis, described compositions comprises the material of following weight portion: Cornu Cervi tablet 50-60 part, Radix Gentianae Macrophyllae 55-62 part, Rhizoma Et Radix Notopterygii 55-62 part, Ramulus Mori 55-62 part, Radix Angelicae Sinensis 57-65 part, Radix Salviae Miltiorrhizae 57-65 part, Olibanum 57-65 part, Myrrha 57-65 part, Rhizoma Curcumae Longae 55-62 part, Rhizoma Chuanxiong 55-62 part, Rhizoma Atractylodis 55-62 part, Scorpio 55-60 part, Pheretima 55-60 part, Bombyx Batryticatus 55-60 part, stir-baked SQUAMA MANITIS 55-60 part, Eupolyphaga Seu Steleophaga 55-60 part, Herba speranskiae tuberculatae 55-63 part, Rhizoma Gastrodiae 55-63 part, Radix Notoginseng 55-63 part, Sanguis Draxonis 55-63 part, Radix Aconiti 55-63 part, Radix Aconiti Kusnezoffii 55-63 part, Semen Strychni (processed) 55-63 part, Carapax et Plastrum Testudinis 78-83 part, Zaocys 78-83 part, Radix Clematidis 78-83 part, Rhizoma Drynariae 78-83 part, Radix Paeoniae Alba 118-125 part, Radix Puerariae 118-125 part and Scolopendra 150-200 part
Preferably, described compositions comprises the material of following weight portion: Cornu Cervi tablet 55 parts, Radix Gentianae Macrophyllae 60 parts, Rhizoma Et Radix Notopterygii 60 parts, Ramulus Mori 60 parts, Radix Angelicae Sinensis 60 parts, Radix Salviae Miltiorrhizae 60 parts, Olibanum 60 parts, Myrrha 60 parts, 60 parts, Rhizoma Curcumae Longae, Rhizoma Chuanxiong 60 parts, Rhizoma Atractylodis 60 parts, Scorpio 58 parts, Pheretima 58 parts, Bombyx Batryticatus 58 parts, stir-baked SQUAMA MANITIS 58 parts, Eupolyphaga Seu Steleophaga 58 parts, Herba speranskiae tuberculatae 60 parts, 60 parts, Rhizoma Gastrodiae, Radix Notoginseng 60 parts, Sanguis Draxonis 60 parts, Radix Aconiti 60 parts, Radix Aconiti Kusnezoffii 60 parts, Semen Strychni (processed) 60 parts, Carapax et Plastrum Testudinis 80 parts, Zaocys 80 parts, Radix Clematidis 80 parts, Rhizoma Drynariae 80 parts, the Radix Paeoniae Alba 120 parts, Radix Puerariae 120 parts and Scolopendra 182 parts.
More preferably, described compositions also comprises the material of following weight portion: Herba Portulacae Grandiflorae 90 parts, Herba Liparidis nervosae 80 parts, Radix et Rhizoma Iridis Sanguineae 70 parts, Radix seu Caulis fici Martinii grass 75 parts, Herba Psiloti Nudi 80 parts, Herba Cissampelotis pareiae 70 parts, Membrana Follicularis ovi 90 parts, bitter white hoof 80 parts, Semen Sterculiae Nobilis 70 parts, 80 parts, calabash rattan, Herba Desmodii Elegantis 60 parts and Herba Potentillae Fragarioidis 60 parts.
Most preferably, described Chinese medicine can be tablet, dispersible tablet, capsule, unguentum or decoction.
Chinese medicine composition of the present invention interacts, and synergism is evident in efficacy, highly widelys popularize.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
Embodiment 1 unguentum of the present invention
Take Cornu Cervi tablet 55 grams, Radix Gentianae Macrophyllae 60 grams, Rhizoma Et Radix Notopterygii 60 grams, Ramulus Mori 60 grams, Radix Angelicae Sinensis 60 grams, Radix Salviae Miltiorrhizae 60 grams, Olibanum 60 grams, Myrrha 60 grams, 60 grams, Rhizoma Curcumae Longae, Rhizoma Chuanxiong 60 grams, Rhizoma Atractylodis 60 grams, Scorpio 58 grams, Pheretima 58 grams, Bombyx Batryticatus 58 grams, stir-baked SQUAMA MANITIS 58 grams, Eupolyphaga Seu Steleophaga 58 grams, Herba speranskiae tuberculatae 60 grams, 60 grams, Rhizoma Gastrodiae, Radix Notoginseng 60 grams, Sanguis Draxonis 60 grams, Radix Aconiti 60 grams, Radix Aconiti Kusnezoffii 60 grams, Semen Strychni (processed) 60 grams, Carapax et Plastrum Testudinis 80 grams, Zaocys 80 grams, Radix Clematidis 80 grams, Rhizoma Drynariae 80 grams, the Radix Paeoniae Alba 120 grams, Radix Puerariae 120 grams and Scolopendra 182 grams, pulverize, cross 60 mesh sieves, add 900 grams, vaseline and lanoline 800 grams, stir, obtain.
Embodiment 2 unguentum of the present invention
Take Cornu Cervi tablet 55 grams, Radix Gentianae Macrophyllae 60 grams, Rhizoma Et Radix Notopterygii 60 grams, Ramulus Mori 60 grams, Radix Angelicae Sinensis 60 grams, Radix Salviae Miltiorrhizae 60 grams, Olibanum 60 grams, Myrrha 60 grams, 60 grams, Rhizoma Curcumae Longae, Rhizoma Chuanxiong 60 grams, Rhizoma Atractylodis 60 grams, Scorpio 58 grams, Pheretima 58 grams, Bombyx Batryticatus 58 grams, stir-baked SQUAMA MANITIS 58 grams, Eupolyphaga Seu Steleophaga 58 grams, Herba speranskiae tuberculatae 60 grams, 60 grams, Rhizoma Gastrodiae, Radix Notoginseng 60 grams, Sanguis Draxonis 60 grams, Radix Aconiti 60 grams, Radix Aconiti Kusnezoffii 60 grams, Semen Strychni (processed) 60 grams, Carapax et Plastrum Testudinis 80 grams, Zaocys 80 grams, Radix Clematidis 80 grams, Rhizoma Drynariae 80 grams, the Radix Paeoniae Alba 120 grams, Radix Puerariae 120 grams, Scolopendra 182 grams, Herba Portulacae Grandiflorae 90 grams, Herba Liparidis nervosae 80 grams, Radix et Rhizoma Iridis Sanguineae 70 grams, Radix seu Caulis fici Martinii grass 75 grams, Herba Psiloti Nudi 80 grams, Herba Cissampelotis pareiae 70 grams, Membrana Follicularis ovi 90 grams, bitter white hoof 80 grams, Semen Sterculiae Nobilis 70 grams, 80 grams, calabash rattan, Herba Desmodii Elegantis 60 grams and Herba Potentillae Fragarioidis 60 grams, pulverize, cross 60 mesh sieves, add 900 grams, vaseline and lanoline 800 grams, stir, obtain.
Experimental example
Diagnostic criteria
Western medicine diagnose standard:
Diagnosis cervical spondylosis standard according to the 3rd national cervical spondylosis symposium (2008) is formulated:
(1) there is typical clinical symptoms (neck-shoulder pain, upper limb numbness etc.), and the scope that its distribution and cervical nerves are arranged is consistent;
(2) brachial plexus nerve distraction test or the head test positive;
(3) be consistent with clinical manifestation shown in the iconography such as x-ray, MR;
(4) what get rid of that (thoracic outlet syndrome, scapulohumeral periarthritis, bicipital tenosynovitis, external humeral epicondylitis, cubital tunnel syndrome and carpal tunnel syndrome etc.) beyond cervical spondylosis cause take upper extremity pain as the disease of primary symptom.
Traditional Chinese medical science pigtail card standard:
TCM syndrome diagnostic criteria (stagnation of QI blood addiction card) is formulated in " the clinical guidance principle of new Chinese medicine guideline of clinical investigations new Chinese medicine treatment cervical spondylosis " amendment:
Primary symptom: neck pain, neck contracture, movable unfavorable, upper extremity pain, disease of hand;
Secondary disease: dim complexion, xerosis cutis are matt;
Picture of the tongue: the light red or purple of body of the tongue secretly has ecchymosis;
Pulse condition: stringy pulse or puckery.
Primary symptom meet 3 and more than, secondary disease meet 1 and more than, in conjunction with tongue, pulse condition, just diagnosable.
Inclusive criteria:
(1) meet the patient of Western medicine diagnose standard and traditional Chinese medical science pigtail card standard simultaneously;
(2) male or female, the age is between 30-70 year;
(3) experimenter does not accept the treatment of therapeutic modality and the quasi drugs of the same race of being correlated with before observation in 2 weeks;
(4) experimenter need sign Informed Consent Form, can actively coordinate.
Meet above all standard person can include in simultaneously.
Exclusion standard:
(1) above diagnostic criteria or inclusive criteria person is not met;
(2) age <30 year or >70 year;
(3) with disease and insanes such as the serious heart, liver, kidney and digestive system, the observer that may affect the treatment;
(4) other non-cervical spondylotic radiculopathy patient such as fracture-dislocation of cervical spine, tuberculosis or tumor, spinal canal stenosis etc.;
(5) allergic constitution person or be in pregnantly to shake, the women of age of sucking;
(6) do not accept other associated treatment again by predetermined treatment or treatments period, curative effect or the onlooker that affects the treatment cannot be judged;
Selector close standard of stating patient 100 example, wherein man 50 example, female 50 example, patient age 35-62 year, the mean age be (43+5) year, be two groups by patient, be respectively treatment group 1 and treatment group 2, often group has 50 routine patients.Two groups of Genders, age, the course of disease, symptom there are no significant difference, have comparability (P > 0.05).
Treatment group 1 uses the unguentum of preparation in embodiment 1 to treat, every day three times, each affected part using 20 grams of unguentum to be coated in patient equably, continuously treatment 2 weeks.
Treatment group 2 uses the unguentum of preparation in embodiment 2 to treat, every day three times, each affected part using 20 grams of unguentum to be coated in patient equably, continuously treatment 2 weeks.
Criterion of therapeutical effect
1. clinical cure: clinical symptom disappearance, cervical vertebra moving freely, has recovered normal work; 2. effective: clinical symptoms disappears substantially, neck and shoulder part is even discomfort, can extensive recovery operation; 3. invalid: clinical symptoms, sign are without alleviation.
Statistical method
Utilize SPSS13.0 software to process and analyze to experimental data, measurement data is with mean ± standard deviation
represent, adopt t inspection, enumeration data adopts x
2inspection, P < 0.05 represents that difference has statistical significance.
Therapeutic outcome
For treatment group 1, clinical cure 21 example, effective 20 examples, no effect 9, total effective rate is 82%; For treatment group 2, clinical cure 23 example, effective 24 examples, invalid 3 examples, total effective rate is 94%.Two groups of total effective rate comparing differences have statistical significance (P < 0.05).The effect for the treatment of group 2 is better than the effect for the treatment of group 1.
Carry out the monitoring of blood, urine, stool routine examination and hepatic and renal function to two groups of patients before and after treatment, in time monitoring untoward reaction occurs, and it compares and sees the following form:
Claims (8)
1. treat the Chinese medicine composition of cervical spondylosis for one kind, it is characterized in that, it comprises the material of following weight portion: Cornu Cervi tablet 50-60 part, Radix Gentianae Macrophyllae 55-62 part, Rhizoma Et Radix Notopterygii 55-62 part, Ramulus Mori 55-62 part, Radix Angelicae Sinensis 57-65 part, Radix Salviae Miltiorrhizae 57-65 part, Olibanum 57-65 part, Myrrha 57-65 part, Rhizoma Curcumae Longae 55-62 part, Rhizoma Chuanxiong 55-62 part, Rhizoma Atractylodis 55-62 part, Scorpio 55-60 part, Pheretima 55-60 part, Bombyx Batryticatus 55-60 part, stir-baked SQUAMA MANITIS 55-60 part, Eupolyphaga Seu Steleophaga 55-60 part, Herba speranskiae tuberculatae 55-63 part, Rhizoma Gastrodiae 55-63 part, Radix Notoginseng 55-63 part, Sanguis Draxonis 55-63 part, Radix Aconiti 55-63 part, Radix Aconiti Kusnezoffii 55-63 part, Semen Strychni (processed) 55-63 part, Carapax et Plastrum Testudinis 78-83 part, Zaocys 78-83 part, Radix Clematidis 78-83 part, Rhizoma Drynariae 78-83 part, Radix Paeoniae Alba 118-125 part, Radix Puerariae 118-125 part and Scolopendra 150-200 part.
2. the Chinese medicine composition for the treatment of cervical spondylosis according to claim 1, it is characterized in that, it comprises the material of following weight portion: Cornu Cervi tablet 55 parts, Radix Gentianae Macrophyllae 60 parts, Rhizoma Et Radix Notopterygii 60 parts, Ramulus Mori 60 parts, Radix Angelicae Sinensis 60 parts, Radix Salviae Miltiorrhizae 60 parts, Olibanum 60 parts, Myrrha 60 parts, 60 parts, Rhizoma Curcumae Longae, Rhizoma Chuanxiong 60 parts, Rhizoma Atractylodis 60 parts, Scorpio 58 parts, Pheretima 58 parts, Bombyx Batryticatus 58 parts, stir-baked SQUAMA MANITIS 58 parts, Eupolyphaga Seu Steleophaga 58 parts, Herba speranskiae tuberculatae 60 parts, 60 parts, Rhizoma Gastrodiae, Radix Notoginseng 60 parts, Sanguis Draxonis 60 parts, Radix Aconiti 60 parts, Radix Aconiti Kusnezoffii 60 parts, Semen Strychni (processed) 60 parts, Carapax et Plastrum Testudinis 80 parts, Zaocys 80 parts, Radix Clematidis 80 parts, Rhizoma Drynariae 80 parts, the Radix Paeoniae Alba 120 parts, Radix Puerariae 120 parts and Scolopendra 182 parts.
3. the Chinese medicine composition for the treatment of cervical spondylosis according to claim 1 and 2, it is characterized in that, it also comprises the material of following weight portion: Herba Portulacae Grandiflorae 90 parts, Herba Liparidis nervosae 80 parts, Radix et Rhizoma Iridis Sanguineae 70 parts, Radix seu Caulis fici Martinii grass 75 parts, Herba Psiloti Nudi 80 parts, Herba Cissampelotis pareiae 70 parts, Membrana Follicularis ovi 90 parts, bitter white hoof 80 parts, Semen Sterculiae Nobilis 70 parts, 80 parts, calabash rattan, Herba Desmodii Elegantis 60 parts and Herba Potentillae Fragarioidis 60 parts.
4. the Chinese medicine composition for the treatment of cervical spondylosis according to claim 3, is characterized in that, described Chinese medicine composition can be tablet, dispersible tablet, capsule, unguentum or decoction.
5. the purposes of compositions in the Chinese medicine of preparation treatment cervical spondylosis, it is characterized in that, described compositions comprises the material of following weight portion: Cornu Cervi tablet 50-60 part, Radix Gentianae Macrophyllae 55-62 part, Rhizoma Et Radix Notopterygii 55-62 part, Ramulus Mori 55-62 part, Radix Angelicae Sinensis 57-65 part, Radix Salviae Miltiorrhizae 57-65 part, Olibanum 57-65 part, Myrrha 57-65 part, Rhizoma Curcumae Longae 55-62 part, Rhizoma Chuanxiong 55-62 part, Rhizoma Atractylodis 55-62 part, Scorpio 55-60 part, Pheretima 55-60 part, Bombyx Batryticatus 55-60 part, stir-baked SQUAMA MANITIS 55-60 part, Eupolyphaga Seu Steleophaga 55-60 part, Herba speranskiae tuberculatae 55-63 part, Rhizoma Gastrodiae 55-63 part, Radix Notoginseng 55-63 part, Sanguis Draxonis 55-63 part, Radix Aconiti 55-63 part, Radix Aconiti Kusnezoffii 55-63 part, Semen Strychni (processed) 55-63 part, Carapax et Plastrum Testudinis 78-83 part, Zaocys 78-83 part, Radix Clematidis 78-83 part, Rhizoma Drynariae 78-83 part, Radix Paeoniae Alba 118-125 part, Radix Puerariae 118-125 part and Scolopendra 150-200 part.
6. purposes according to claim 5, it is characterized in that, described compositions comprises the material of following weight portion: Cornu Cervi tablet 55 parts, Radix Gentianae Macrophyllae 60 parts, Rhizoma Et Radix Notopterygii 60 parts, Ramulus Mori 60 parts, Radix Angelicae Sinensis 60 parts, Radix Salviae Miltiorrhizae 60 parts, Olibanum 60 parts, Myrrha 60 parts, 60 parts, Rhizoma Curcumae Longae, Rhizoma Chuanxiong 60 parts, Rhizoma Atractylodis 60 parts, Scorpio 58 parts, Pheretima 58 parts, Bombyx Batryticatus 58 parts, stir-baked SQUAMA MANITIS 58 parts, Eupolyphaga Seu Steleophaga 58 parts, Herba speranskiae tuberculatae 60 parts, 60 parts, Rhizoma Gastrodiae, Radix Notoginseng 60 parts, Sanguis Draxonis 60 parts, Radix Aconiti 60 parts, Radix Aconiti Kusnezoffii 60 parts, Semen Strychni (processed) 60 parts, Carapax et Plastrum Testudinis 80 parts, Zaocys 80 parts, Radix Clematidis 80 parts, Rhizoma Drynariae 80 parts, the Radix Paeoniae Alba 120 parts, Radix Puerariae 120 parts and Scolopendra 182 parts.
7. the purposes according to claim 5 or 6, it is characterized in that, described compositions also comprises the material of following weight portion: Herba Portulacae Grandiflorae 90 parts, Herba Liparidis nervosae 80 parts, Radix et Rhizoma Iridis Sanguineae 70 parts, Radix seu Caulis fici Martinii grass 75 parts, Herba Psiloti Nudi 80 parts, Herba Cissampelotis pareiae 70 parts, Membrana Follicularis ovi 90 parts, bitter white hoof 80 parts, Semen Sterculiae Nobilis 70 parts, 80 parts, calabash rattan, Herba Desmodii Elegantis 60 parts and Herba Potentillae Fragarioidis 60 parts.
8. purposes according to claim 7, is characterized in that, described Chinese medicine can be tablet, dispersible tablet, capsule, unguentum or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510539678.1A CN105056144A (en) | 2015-08-28 | 2015-08-28 | Chinese herb composition for treating cervical spondylosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510539678.1A CN105056144A (en) | 2015-08-28 | 2015-08-28 | Chinese herb composition for treating cervical spondylosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105056144A true CN105056144A (en) | 2015-11-18 |
Family
ID=54485813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510539678.1A Pending CN105056144A (en) | 2015-08-28 | 2015-08-28 | Chinese herb composition for treating cervical spondylosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105056144A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105726740A (en) * | 2016-04-25 | 2016-07-06 | 林观娣 | Chinese herbal medicine bath preparation and preparing method thereof |
| CN105770977A (en) * | 2016-03-25 | 2016-07-20 | 张月媚 | Bandage for treating non-straightened joints after falling injury and preparation method thereof |
| CN105920376A (en) * | 2016-07-07 | 2016-09-07 | 晁储然 | Traditional Chinese medicine composition for treating cervical spondylosis and neck pain until recovery |
| CN105920184A (en) * | 2016-06-02 | 2016-09-07 | 郑笑遥 | Externally applied Chinese medicinal composition for treating cervical spondylosis and preparation method thereof |
| CN105998592A (en) * | 2016-07-27 | 2016-10-12 | 桐城市泰安中药材种植专业合作社 | Traditional Chinese medicament for treating cervical spondylosis |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101129973A (en) * | 2006-08-25 | 2008-02-27 | 范广友 | Traditional Chinese medicine for treating cervical vertebra disease |
| CN101254282A (en) * | 2008-03-21 | 2008-09-03 | 舒财 | Combination for curing cervical vertebra disease |
| CN103212036A (en) * | 2013-04-19 | 2013-07-24 | 孙波 | Chinese medicament for treating cervical spondylosis |
| CN103417742A (en) * | 2012-05-16 | 2013-12-04 | 刘家坤 | Traditional Chinese medicine for curing cervical spondylosis and lumbar intervertebral disc hernia |
-
2015
- 2015-08-28 CN CN201510539678.1A patent/CN105056144A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101129973A (en) * | 2006-08-25 | 2008-02-27 | 范广友 | Traditional Chinese medicine for treating cervical vertebra disease |
| CN101254282A (en) * | 2008-03-21 | 2008-09-03 | 舒财 | Combination for curing cervical vertebra disease |
| CN103417742A (en) * | 2012-05-16 | 2013-12-04 | 刘家坤 | Traditional Chinese medicine for curing cervical spondylosis and lumbar intervertebral disc hernia |
| CN103212036A (en) * | 2013-04-19 | 2013-07-24 | 孙波 | Chinese medicament for treating cervical spondylosis |
Non-Patent Citations (2)
| Title |
|---|
| 嵇强等: ""中药内服外用治疗颈椎病的研究概况"", 《现代康复》 * |
| 李昭敏等: ""颈椎病中药内治研究进展"", 《中医药研究》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105770977A (en) * | 2016-03-25 | 2016-07-20 | 张月媚 | Bandage for treating non-straightened joints after falling injury and preparation method thereof |
| CN105726740A (en) * | 2016-04-25 | 2016-07-06 | 林观娣 | Chinese herbal medicine bath preparation and preparing method thereof |
| CN105920184A (en) * | 2016-06-02 | 2016-09-07 | 郑笑遥 | Externally applied Chinese medicinal composition for treating cervical spondylosis and preparation method thereof |
| CN105920376A (en) * | 2016-07-07 | 2016-09-07 | 晁储然 | Traditional Chinese medicine composition for treating cervical spondylosis and neck pain until recovery |
| CN105998592A (en) * | 2016-07-27 | 2016-10-12 | 桐城市泰安中药材种植专业合作社 | Traditional Chinese medicament for treating cervical spondylosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105056144A (en) | Chinese herb composition for treating cervical spondylosis | |
| CN100506274C (en) | Traditional Chinese medicine for treating cervical vertebra disease | |
| CN103340976B (en) | Drug for treating neck, shoulder, waist and leg pain | |
| CN104587090A (en) | Medicine for treating rheumatoid arthritis | |
| CN103736067A (en) | Traditional Chinese medicinal composition for treating protrusion of lumbar intervertebral disc | |
| CN104758659A (en) | Traditional Chinese medicine paste for treating muscle and bone diseases | |
| CN104873898A (en) | Preparation, namely blood conducting powder containing kudzuvine root and safflower, for treating hemiplegia | |
| CN101703662B (en) | Oral Chinese medicament for treating hyperosteogeny | |
| CN103301326B (en) | Medicament for treating rheumatism, rheumatoid and pain or rheumatism in lower extremities and waist | |
| CN100420480C (en) | Pillows for mastosis, e.g., hyperplasia, tumours and other diseases | |
| CN104667124A (en) | Traditional Chinese medicine composition capable of treating traumatic injuries and promoting factures to heal quickly | |
| CN105288232A (en) | Traditional Chinese medicine capsule for treating rheumatic bone disease and preparing method thereof | |
| CN102274457A (en) | Physiotherapy enhanced spray for scraping and massaging | |
| CN104998202A (en) | Traditional Chinese medicine for treating cervical spondylosis | |
| CN1240425C (en) | Chinese traditional medicine for treating bone fracture and osteopathy | |
| CN104306621A (en) | Prosopalgia rehabilitation powder | |
| CN103721018A (en) | External traditional Chinese medicinal tincture for treating arthritis | |
| CN103948878B (en) | A kind of Chinese medicine composition for the treatment of osteopathia | |
| CN104491832A (en) | Traditional Chinese medicine composition used for treating osteoproliferation | |
| CN104258326A (en) | Traditional Chinese medicine used for treating scapulohumeral periarthritis | |
| CN104548048A (en) | Traditional Chinese medicine composition for treating rheumatic tendon and bone diseases | |
| CN104800443A (en) | Bone setting agent with functions of tonifying kidney and regenerating bone marrow | |
| CN102772617A (en) | Medicine for treating disease of hyperosteogeny | |
| CN102526385A (en) | Medicament for treating climacteric syndrome | |
| CN104547138A (en) | Traditional Chinese medicine composition for treating rheumatism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151118 |
|
| RJ01 | Rejection of invention patent application after publication |